Market Overview

UPDATE: Goldman Sachs Lowers PT on McKesson Corporation Following ABC/WAG Deal

Share:
Related MCK
NovaBay Signs Distribution Agreement with AmerisourceBergen Corporation for Avenova
Citi: 'Size Matters' For Independent Pharmacies, Still Bullish On AmerisourceBergen And McKesson
Heinz dives into U.S. mustard market (Seeking Alpha)

In a report published Wednesday, Goldman Sachs analyst Robert P. Jones reiterated a Buy rating on McKesson Corporation (NYSE: MCK), but lowered the price target from $124.00 to $122.00.

In the report, Jones noted, “On our new estimates, ABC now trades at a 2x P/E multiple premium to MCK and CAH. While some may argue that ABC's valuation is justifiable given growth and support to numbers from the announced WAG deal, we find it difficult to overcome at current levels and maintain our Neutral rating. We still see the greatest risk/reward in MCK trading essentially at parity with CAH on our CY14, given (1) a more attractive growth profile through CY2014 after CAH's loss of WAG, (2) pending CVS contract renewals, which pose a risk for both, but greater for CAH at 31% of sales, versus MCK at 16%, and (3) a more attractive Specialty footprint - a differentiator in outer years.”

McKesson Corporation closed on Tuesday at $106.87.

Latest Ratings for MCK

DateFirmActionFromTo
Mar 2015Deutsche BankMaintainsBuy
Mar 2015JP MorganMaintainsOverweight
Jan 2015JP MorganMaintainsOverweight

View More Analyst Ratings for MCK
View the Latest Analyst Ratings

Posted-In: Goldman SachsAnalyst Color Price Target Analyst Ratings

 

Related Articles (MCK)

Around the Web, We're Loving...